Dual targeting of ACSS2 and ACLY by a novel inhibitor S8588 suppresses oncogenic lipogenesis and overcomes metabolic compensation in oral squamous cell carcinoma.
- DOI
- 10.1038/s41368-026-00467-y
- Published
- 2026 Oct 31
- Container
- International journal of oral science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41368-026-00467-y,
title = {Dual targeting of ACSS2 and ACLY by a novel inhibitor S8588 suppresses oncogenic lipogenesis and overcomes metabolic compensation in oral squamous cell carcinoma.},
author = {Luo T and Ming Z and Zhang H and Zou Z and Hu X and Yin Y and Wang Y and Zhou Z and Bin X and Wu J and Luo J and Luo Z and Tang Z and Liu O},
year = {2026},
journal = {International journal of oral science},
doi = {10.1038/s41368-026-00467-y},
url = {https://doi.org/10.1038/s41368-026-00467-y}
}RIS
TY - JOUR TI - Dual targeting of ACSS2 and ACLY by a novel inhibitor S8588 suppresses oncogenic lipogenesis and overcomes metabolic compensation in oral squamous cell carcinoma. AU - Luo T AU - Ming Z AU - Zhang H AU - Zou Z AU - Hu X AU - Yin Y AU - Wang Y AU - Zhou Z AU - Bin X AU - Wu J AU - Luo J AU - Luo Z AU - Tang Z AU - Liu O PY - 2026 JO - International journal of oral science DO - 10.1038/s41368-026-00467-y UR - https://doi.org/10.1038/s41368-026-00467-y ER -
APA
T, L., Z, M., H, Z., Z, Z., X, H., Y, Y., Y, W., Z, Z., X, B., J, W., J, L., Z, L., Z, T., & O, L. (2026). Dual targeting of ACSS2 and ACLY by a novel inhibitor S8588 suppresses oncogenic lipogenesis and overcomes metabolic compensation in oral squamous cell carcinoma.. International journal of oral science. https://doi.org/10.1038/s41368-026-00467-y
Source records
- pubmed · retrieved 2026-11-10T21:14:53.103Z